324 related articles for article (PubMed ID: 1677249)
1. [Non-sedative antihistaminics and binding to central and peripheral H1 histamine receptors].
Leysen JE; Gommeren W; Janssen PF; Sanz G; Gillardin JM; Schotte A; Janssen PA
Allerg Immunol (Paris); 1991 Feb; 23(2):51-7. PubMed ID: 1677249
[TBL] [Abstract][Full Text] [Related]
2. In vitro and in vivo binding characteristics of a new long-acting histamine H1 antagonist, astemizole.
Laduron PM; Janssen PF; Gommeren W; Leysen JE
Mol Pharmacol; 1982 Mar; 21(2):294-300. PubMed ID: 6124876
[TBL] [Abstract][Full Text] [Related]
3. In vivo and in vitro interaction of the novel selective histamine H1 receptor antagonist mizolastine with H1 receptors in the rodent.
Benavides J; Schoemaker H; Dana C; Claustre Y; Delahaye M; Prouteau M; Manoury P; Allen J; Scatton B; Langer SZ
Arzneimittelforschung; 1995 May; 45(5):551-8. PubMed ID: 7612054
[TBL] [Abstract][Full Text] [Related]
4. Recent advances in H1-receptor antagonist treatment.
Simons FE
J Allergy Clin Immunol; 1990 Dec; 86(6 Pt 2):995-9. PubMed ID: 1979802
[TBL] [Abstract][Full Text] [Related]
5. The comparative pharmacokinetics of H1-receptor antagonists.
Simons FE; Simons KJ; Chung M; Yeh J
Ann Allergy; 1987 Dec; 59(6 Pt 2):20-4. PubMed ID: 2892445
[TBL] [Abstract][Full Text] [Related]
6. Treatment of urticaria and angioedema: low-sedating H1-type antihistamines.
Soter NA
J Am Acad Dermatol; 1991 Jun; 24(6 Pt 2):1084-7. PubMed ID: 1677011
[TBL] [Abstract][Full Text] [Related]
7. Evaluation of the potential cardiotoxicity of the antihistamines terfenadine, astemizole, loratadine, and cetirizine in atopic children.
Delgado LF; Pferferman A; Solé D; Naspitz CK
Ann Allergy Asthma Immunol; 1998 Apr; 80(4):333-7. PubMed ID: 9564984
[TBL] [Abstract][Full Text] [Related]
8. In vitro and in vivo studies of the non-sedating antihistamine epinastine.
Fügner A; Bechtel WD; Kuhn FJ; Mierau J
Arzneimittelforschung; 1988 Oct; 38(10):1446-53. PubMed ID: 2461715
[TBL] [Abstract][Full Text] [Related]
9. Relationship between occupation of cerebral H1-receptors and sedative properties of antihistamines. Assessment in the case of terfenadine.
Rose C; Quach TT; Llorens C; Schwartz JC
Arzneimittelforschung; 1982; 32(9a):1171-3. PubMed ID: 6129863
[TBL] [Abstract][Full Text] [Related]
10. A double-blind, single-dose, crossover comparison of cetirizine, terfenadine, loratadine, astemizole, and chlorpheniramine versus placebo: suppressive effects on histamine-induced wheals and flares during 24 hours in normal subjects.
Simons FE; McMillan JL; Simons KJ
J Allergy Clin Immunol; 1990 Oct; 86(4 Pt 1):540-7. PubMed ID: 1977781
[TBL] [Abstract][Full Text] [Related]
11. Comparative analysis of the cardiotoxicity proclivities of second generation antihistamines in an experimental model predictive of adverse clinical ECG effects.
Hey JA; del Prado M; Sherwood J; Kreutner W; Egan RW
Arzneimittelforschung; 1996 Feb; 46(2):153-8. PubMed ID: 8720304
[TBL] [Abstract][Full Text] [Related]
12. Pharmacology of antihistamines.
Woodward JK
J Allergy Clin Immunol; 1990 Oct; 86(4 Pt 2):606-12. PubMed ID: 1977782
[TBL] [Abstract][Full Text] [Related]
13. Pharmacological modulation of cutaneous reactivity to histamine: a double-blind acute comparative study between cetirizine, terfenadine and astemizole.
Ghys L; Rihoux JP
J Int Med Res; 1989; 17(1):24-7. PubMed ID: 2565265
[TBL] [Abstract][Full Text] [Related]
14. Nonsedating histamine H1-receptor antagonists.
Mann KV; Crowe JP; Tietze KJ
Clin Pharm; 1989 May; 8(5):331-44. PubMed ID: 2568212
[TBL] [Abstract][Full Text] [Related]
15. Central effects of fexofenadine and cetirizine: measurement of psychomotor performance, subjective sleepiness, and brain histamine H1-receptor occupancy using 11C-doxepin positron emission tomography.
Tashiro M; Sakurada Y; Iwabuchi K; Mochizuki H; Kato M; Aoki M; Funaki Y; Itoh M; Iwata R; Wong DF; Yanai K
J Clin Pharmacol; 2004 Aug; 44(8):890-900. PubMed ID: 15286093
[TBL] [Abstract][Full Text] [Related]
16. H1-receptor antagonist treatment of seasonal allergic rhinitis.
Kaiser HB
J Allergy Clin Immunol; 1990 Dec; 86(6 Pt 2):1000-3. PubMed ID: 1979793
[TBL] [Abstract][Full Text] [Related]
17. Molecular basis for the lack of HERG K+ channel block-related cardiotoxicity by the H1 receptor blocker cetirizine compared with other second-generation antihistamines.
Taglialatela M; Pannaccione A; Castaldo P; Giorgio G; Zhou Z; January CT; Genovese A; Marone G; Annunziato L
Mol Pharmacol; 1998 Jul; 54(1):113-21. PubMed ID: 9658196
[TBL] [Abstract][Full Text] [Related]
18. Pharmacokinetic overview of oral second-generation H1 antihistamines.
González MA; Estes KS
Int J Clin Pharmacol Ther; 1998 May; 36(5):292-300. PubMed ID: 9629995
[TBL] [Abstract][Full Text] [Related]
19. Analytical method for simultaneously measuring ex vivo drug receptor occupancy and dissociation rate: application to (R)-dimethindene occupancy of central histamine H1 receptors.
Malany S; Hernandez LM; Smith WF; Crowe PD; Hoare SR
J Recept Signal Transduct Res; 2009; 29(2):84-93. PubMed ID: 19308787
[TBL] [Abstract][Full Text] [Related]
20. Inhibition of the cutaneous response to histamine by H1-blocking agents. Quantitative evaluation of microvascular changes in the skin after histamine challenge and a comparison of the effects of a single intake of cetirizine and terfenadine.
Van Neste D; Rihoux JP
Skin Pharmacol; 1988; 1(3):192-9. PubMed ID: 2908486
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]